Abstract Objectives The German Pharmaceutical Market Restructuring Act (AMNOG, 2011)
is a two-stage process to regulate the price of new pharmaceuticals in which price …

Background: Ambulatory Care Sensitive Conditions (ACSC) are health conditions for which
adequate management, treatment and interventions delivered in outpatient setting could …

There is growing interest in cost-effectiveness thresholds as a tool to inform resource
allocation decisions in health care. Studies from several countries have sought to estimate …

Public discourse on medicine provision predominantly focuses on overall expenditure.
However, current literature suggests measurement of alternative indicators can provide a …

This study aims to estimate the theoretical excess expenditure that would be incurred by the
Irish state-payer, should drugs be reimbursed at their original asking (“list”) price rather than …

Az egészség keresletként határozható meg, amelyet a véges erőforrásokkal rendelkező
egészségügyi rendszer biztosít kínálati oldalról. Bármilyen egészség-nyereség társadalmi …

Se desconoce la relación costo-efectividad de la AFAED en el tratamiento de RNPT en la
UCIN. Resultan interesantes las posibles implicaciones económicas de utilizarla como …

Gene therapies delivered through a single administration have revolutionized treatment
possibilities for many patients living with serious or fatal conditions such as spinal muscular …

The efficient allocation of scarce health care resources is an important but difficult task.
Health economic evaluation, and more specifically, cost-effectiveness analysis, can be a …

RESUMO INTRODUÇÃO: Em análises de custo-efetividade, a razão de custo-efetividade
incremental deve ser comparada a um limiar de custo-efetividade para possibilitar uma …